Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19730 | 428 | 28.6 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN | Address | 9 | 50% | 3% | 13 |
2 | MEDITERRANEAN HEMATOL | Address | 9 | 50% | 3% | 13 |
3 | TR IANTO MIDOLLO OSSEO MURAGLIA | Address | 6 | 71% | 1% | 5 |
4 | STABLE MIXED CHIMERISM | Author keyword | 2 | 67% | 0% | 2 |
5 | TR IANTO MIDOLLO OSSEO | Address | 2 | 26% | 1% | 6 |
6 | EX THALASSEMICS | Author keyword | 1 | 100% | 0% | 2 |
7 | REDUCED INTENSITY PREPARATIVE REGIMENS | Author keyword | 1 | 100% | 0% | 2 |
8 | TR IANTI MIDOLLO OSSEO MURAGLIA | Address | 1 | 29% | 1% | 4 |
9 | SENSITIZED RECIPIENT | Author keyword | 1 | 40% | 0% | 2 |
10 | UNITA OPERATIVA EMATOL | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NONMALIGNANT DISORDERS | 2 | 50% | 1% | 3 |
2 | DISEASE SCD | 1 | 50% | 0% | 2 |
3 | MULTIPLY TRANSFUSED PATIENTS | 1 | 40% | 0% | 2 |
4 | GLOBIN GENE THERAPY | 1 | 50% | 0% | 1 |
5 | NETWORK BMT CTN | 1 | 50% | 0% | 1 |
6 | PROGENITOR CELL COLLECTIONS | 1 | 50% | 0% | 1 |
7 | SEVERE HEMOGLOBINOPATHIES | 1 | 50% | 0% | 1 |
8 | SIROLIMUS MONOTHERAPY | 1 | 50% | 0% | 1 |
9 | DIMETHYL MYLERAN | 0 | 20% | 0% | 2 |
10 | THALASSEMIC PATIENTS | 0 | 10% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia | 2014 | 8 | 59 | 68% |
Hematopoietic stem cell transplantation for sickle cell disease: state of the science | 2015 | 1 | 44 | 59% |
Advances in the allogeneic transplantation for thalassemia | 2008 | 64 | 48 | 58% |
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future | 2008 | 47 | 50 | 60% |
The cure of thalassemia by bone marrow transplantation | 2002 | 84 | 12 | 50% |
Blood and marrow transplantation for sickle cell disease: overcoming barriers to success | 2009 | 10 | 16 | 94% |
Hematopoietic Stem Cell Transplantation for Thalassemia | 2011 | 12 | 39 | 67% |
Sickle cell disease: time for a closer look at treatment options? | 2013 | 12 | 49 | 37% |
Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease | 2012 | 15 | 50 | 46% |
Recent Advances in Bone Marrow Transplantation in Hemoglobinopathies | 2008 | 19 | 74 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN | 9 | 50% | 3.0% | 13 |
2 | MEDITERRANEAN HEMATOL | 9 | 50% | 3.0% | 13 |
3 | TR IANTO MIDOLLO OSSEO MURAGLIA | 6 | 71% | 1.2% | 5 |
4 | TR IANTO MIDOLLO OSSEO | 2 | 26% | 1.4% | 6 |
5 | TR IANTI MIDOLLO OSSEO MURAGLIA | 1 | 29% | 0.9% | 4 |
6 | UNITA OPERATIVA EMATOL | 1 | 40% | 0.5% | 2 |
7 | CANC BLOOD DISORDERS NORTHERN VIRGINIA | 1 | 50% | 0.2% | 1 |
8 | EMATOL FORENSE | 1 | 50% | 0.2% | 1 |
9 | FDN IRCCS POLICLIN SAN MATEO | 1 | 50% | 0.2% | 1 |
10 | HEMATOL MALIGNANCIES BONE MARROW TRANSPLANTAT P | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234399 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
2 | 0.0000174316 | DONOR CELL LEUKEMIA//CHIMERISM//STR PCR |
3 | 0.0000142727 | SICKLE CELL DISEASE//ACUTE CHEST SYNDROME//SICKLE CELL ANEMIA |
4 | 0.0000142695 | FETAL HEMOGLOBIN//HEMOGLOBINOPATHY THALASSEMIA UNIT//HYDROXYUREA |
5 | 0.0000142559 | CORD BLOOD TRANSPLANTATION//UMBILICAL CORD BLOOD//CORD BLOOD |
6 | 0.0000136668 | DEFERASIROX//IRON OVERLOAD//DEFERIPRONE |
7 | 0.0000133411 | THALASSEMIA MAJOR//MOL DIAGNOST BIOPHARMACEUT//BETA THALASSEMIA MAJOR |
8 | 0.0000131645 | TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE |
9 | 0.0000105858 | DEV MODEL//PROTEIN WORD//DEV |
10 | 0.0000105233 | HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION |